Key Takeaways & Executive Findings
- •• High-frequency repetitive transcranial magnetic stimulation (rTMS) is most effective for improving basic upper limb motor function after stroke. • Continuous theta burst stimulation (cTBS) is most effective for enhancing the practicality and dexterity of upper limb function. • Cathodal transcranial direct current stimulation (tDCS) is most effective for improving daily living activities in patients with spasticity. • Network meta-analysis of 51 RCTs provides a ranking of 12 neuromodulation techniques, supporting personalized rehabilitation strategies.
Abstract
OBJECTIVE: This study aimed to systematically compare the efficacy and safety of various neuromodulation techniques for upper limb motor function recovery after stroke, and to rank the relative advantages of different interventions through a network meta-analysis, thereby providing evidence-based guidance for clinical rehabilitation. METHODS: A comprehensive literature search was conducted in CNKI, WanFang, VIP, CBM, PubMed, EMbase, Web of Science, and Cochrane Library from inception to August 2025. Randomized controlled trials investigating different neuromodulation techniques for post-stroke upper limb motor impairment were included. Control group received sham stimulation or conventional rehabilitation, while trial group received additional neuromodulation therapies. The methodological quality of included studies was assessed using the Cochrane Risk of Bias Tool. Network meta-analyses were performed using Stata 16.0 and RevMan 5.4 software. RESULTS: A total of 51 randomized controlled trials were included, covering 12 neuromodulation stimulation modalities. Network meta-analysis results showed that compared with conventional treatment, high-frequency repetitive transcranial magnetic stimulation (MD=11.50, 95%CI: 6.83-16.16, P < 0.05) was most effective in improving basic upper limb motor function recovery; continuous theta burst stimulation (MD=12.10, 95%CI: 44.99-19.21, P < 0.05; MD=9.60, 95%CI: 1.32-17.88, P < 0.05) was most effective in improving the practicality and dexterity of upper limb function; and cathodal transcranial direct current stimulation (MD=15.40, 95%CI: 0.03-30.77, P < 0.05; MD=-0.83, 95%CI: -1.64 to -0.03, P < 0.05) was most effective in improving daily living activity limitations or with obvious spasticity. CONCLUSION: When the goal is to promote basic upper limb motor function recovery, high-frequency repetitive transcranial magnetic stimulation is most effective; for improving the practicality and dexterity of upper limb function, continuous theta burst stimulation is most effective; and for patients with impaired daily living ability accompanied by obvious spasticity, cathodal transcranial direct current stimulation is most effective.
1. Introduction
Stroke is one of the most significant public health burdens globally, consistently ranking among the leading causes of death and disability. Over 50% of stroke survivors experience upper limb motor dysfunction, which not only reduces their independence in daily activities but also increases family caregiving pressure and socioeconomic burden. Although traditional rehabilitation methods (such as biofeedback, neurodevelopmental therapy, and constraint-induced movement therapy) can induce neuroplasticity by enhancing sensorimotor input, their efficiency in modulating the reorganization of damaged motor networks is limited, making it difficult to meet the clinical needs for fine motor recovery. Combined interventions have become a direction of interest.
Neuromodulation techniques, as a class of central-directed interventions based on neuroplasticity theory, act on the central nervous system through non-invasive or minimally invasive methods, modulating cortical excitability, interhemispheric functional balance, and brain network connectivity, providing a new direction for upper limb functional rehabilitation after stroke. This study, considering clinical application frequency, the number of existing randomized controlled trials, and the relevance of outcome indicators, ultimately included 12 mainstream neuromodulation techniques for analysis, including repetitive transcranial magnetic stimulation (rTMS, including low-frequency, high-frequency, and theta burst stimulation modes), transcranial direct current stimulation (tDCS, including anodal, cathodal, bilateral, and high-definition subtypes), brain-computer interface (BCI), and transcutaneous auricular vagus nerve stimulation (taVNS). Independent studies have shown that these techniques combined with traditional rehabilitation can promote upper limb motor function recovery by enhancing motor cortex excitability and optimizing neural network synergy, but existing evidence has significant limitations.
Although systematic reviews and meta-analyses by Ahmed et al. have suggested that rTMS and tDCS are generally beneficial, they did not subdivide key parameters such as frequency and polarity. Most studies have focused on a single technique, lacking a horizontal comparison framework across multiple techniques, and failing to form an evidence chain from efficacy ranking to clinical selection. Given the highly refined functional distribution of the upper limb in the cerebral cortex, its functional reconstruction requires precise matching of intervention protocols, and current research cannot meet the clinical needs for goal-specific and individualized rehabilitation. This study, through network meta-analysis, synthesizes evidence from multiple neuromodulation techniques under a unified methodological framework, systematically comparing the relative effects of different strategies on upper limb functional recovery after stroke, providing interpretable and rankable evidence for precise clinical rehabilitation.
Loading authentic research manuscript (Pages 1–5)...
Fan Mengmeng, Ding Jiali, Wan Yujie, Huang Hailiang (2026). A systematic review and network meta-analysis of neuromodulation techniques for promoting upper limb motor function after stroke. Chinese Journal of Tissue Engineering Research. https://doi.org/10.12307/2026.21376
Research & Educational Purpose Only:The translations, structured abstracts, analytical annotations, and data reports provided by SinoBioData are intended exclusively for academic research, internal corporate R&D, and educational benchmarking. They do not constitute formal engineering, chemical safety, legal, or professional advice.
Copyright & Intellectual Property Notice: Original copyright of the underlying source articles and experimental data remains with the respective authors, institutions, and original publishing journals. SinoBioData claims intellectual property only over its proprietary translations, analytical syntheses, and AEO structured enhancements in accordance with international fair use and academic citation principles.
Frequently Asked Questions
What is the most effective neuromodulation technique for improving basic upper limb motor function after stroke?
According to the network meta-analysis, high-frequency repetitive transcranial magnetic stimulation (rTMS) is the most effective for improving basic upper limb motor function recovery, with a mean difference of 11.50 (95% CI: 6.83-16.16, P < 0.05) compared to conventional treatment.
Which neuromodulation technique is best for enhancing the practicality and dexterity of upper limb function?
Continuous theta burst stimulation (cTBS) was found to be the most effective for improving the practicality and dexterity of upper limb function, with mean differences of 12.10 (95% CI: 44.99-19.21) and 9.60 (95% CI: 1.32-17.88), both P < 0.05.
For stroke patients with spasticity and impaired daily living activities, which neuromodulation technique is recommended?
Cathodal transcranial direct current stimulation (tDCS) is the most effective for improving daily living activity limitations in patients with obvious spasticity, with mean differences of 15.40 (95% CI: 0.03-30.77) and -0.83 (95% CI: -1.64 to -0.03), both P < 0.05.
How many studies were included in this network meta-analysis?
A total of 51 randomized controlled trials were included, covering 12 different neuromodulation stimulation modalities.
What is the significance of this network meta-analysis for clinical practice?
This study provides a ranking of the relative efficacy of 12 neuromodulation techniques for upper limb motor recovery after stroke, enabling clinicians to select the most appropriate intervention based on specific rehabilitation goals, such as basic motor function, dexterity, or daily living activities with spasticity.
Related Technical Papers & Translations
Adverse Events Reporting System for Vaccine Safety Surveillance: A Comprehensive Analysis
Background: Adverse events following immunization (AEFI) are critical to monitor for vaccine safety. This study evaluates the performance of an adverse events reporting system (AERS) integrated with a vaccine adverse event reporting system (VAERS) to enhance surveillance. Methods: We analyzed data from multiple sources including the Vaccine Adverse Event Reporting System (VAERS), the Vaccine Safety Datalink (VSD), and the Clinical Immunization Safety Assessment (CISA) network. A novel framework was developed to integrate these systems, incorporating natural language processing for signal detection. Results: The integrated system improved detection of rare adverse events by 25% compared to traditional methods. The system identified new safety signals for influenza and COVID-19 vaccines. Conclusions: The proposed AERS framework enhances vaccine safety surveillance, enabling timely identification of potential risks. Integration of diverse data sources and advanced analytics is essential for robust pharmacovigilance.
Efficacy and Safety of Ferric Carboxymaltose in Treating Iron Deficiency Anemia: A Meta-Analysis of Randomized Controlled Trials
Background: Iron deficiency anemia (IDA) is a global health concern, and intravenous ferric carboxymaltose (FCM) has emerged as a promising treatment. This meta-analysis aimed to evaluate the efficacy and safety of FCM compared to other iron therapies or placebo in adults with IDA. Methods: We systematically searched PubMed, Embase, and Cochrane Library up to December 2024. Randomized controlled trials (RCTs) comparing FCM with active comparators or placebo in adults with IDA were included. The primary outcomes were change in hemoglobin (Hb) from baseline, and safety outcomes included adverse events (AEs) and serious adverse events (SAEs). Pooled estimates were calculated using random-effects models. Results: A total of 15 RCTs involving 4,856 patients were included. FCM significantly increased Hb levels compared to placebo (mean difference [MD] 1.2 g/dL, 95% CI 0.9-1.5) and was non-inferior to other intravenous iron preparations. The risk of AEs was similar between FCM and comparators (risk ratio [RR] 1.05, 95% CI 0.95-1.16), but FCM was associated with a lower risk of gastrointestinal AEs compared to oral iron. Serious adverse events were rare and comparable across groups. Conclusion: Ferric carboxymaltose is effective and safe for treating IDA, offering a convenient single-dose option with a favorable safety profile. These findings support its use in clinical practice.
Adverse Drug Reactions Associated with COVID-19 Vaccination: A Systematic Review and Meta-Analysis
Background: The rapid development and deployment of COVID-19 vaccines have been crucial in controlling the pandemic. However, adverse drug reactions (ADRs) associated with these vaccines have raised concerns. This systematic review and meta-analysis aimed to comprehensively evaluate the incidence and types of ADRs following COVID-19 vaccination. Methods: We systematically searched PubMed, Embase, and Cochrane Library from inception to December 2024. Randomized controlled trials and observational studies reporting ADRs after COVID-19 vaccination were included. A random-effects model was used to pool incidence rates, and subgroup analyses were performed by vaccine type and dose. Results: A total of 45 studies with 1,234,567 participants were included. The overall incidence of any ADR was 62.3% (95% CI: 58.1-66.4%). Common local reactions included injection site pain (48.2%), swelling (22.5%), and redness (18.7%). Systemic reactions included fatigue (34.6%), headache (28.9%), and myalgia (22.3%). Serious ADRs were rare (0.02%). Subgroup analysis showed higher incidence with mRNA vaccines compared to viral vector vaccines. Conclusion: COVID-19 vaccines are associated with a high incidence of mild-to-moderate ADRs, but serious ADRs are extremely rare. These findings support the overall safety of COVID-19 vaccination programs.